Quetiapine for treatment of refractory symptoms of combat-related post-traumatic stress disorder

Military Medicine

Volumn 168, Issue 6, 2003, Pages 486-489

  Sokolski, Kenneth N ^a,b   Denson, Thomas F ^a   Lee, Robert T ^a   Reist, Christopher ^a,b  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTICONVULSIVE AGENT; BENZODIAZEPINE; CARBAMAZEPINE; CLOZAPINE; FLUOXETINE; GABAPENTIN; LITHIUM; MIRTAZAPINE; NEFAZODONE; OLANZAPINE; PHENELZINE; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; TEMAZEPAM; THIORIDAZINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; ZOLPIDEM;

ADULT; AGED; AGITATION; ANTIBODY SCREENING; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG WITHDRAWAL; FATIGUE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MILITARY SERVICE; MUSCLE TWITCH; NAUSEA; NIGHTMARE; OUTPATIENT; POSTTRAUMATIC STRESS DISORDER; PSYCHIATRIC DIAGNOSIS; REFRACTORY PERIOD; RETROSPECTIVE STUDY; SIDE EFFECT; SOLDIER; TREATMENT OUTCOME; VERTIGO; WAR; WEIGHT GAIN; XEROSTOMIA;

EID: 0038130785     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.1093/milmed/168.6.486     Document Type: Article

References (40)

1. Frueh BC, Mirabella RF, Chobot K, Fossey MD: Chronicity of symptoms in combat veterans with PTSD treated by the VA mental health system. Psychol Rep 1994: 75: 843-8.
2. Hidalgo R, Hertzberg MA, Mellman T, et al: Nefazodone in post-traumatic stress disorder: results from six open-label trials. Int J Clin Psychopharmacol 1999: 14: 61-8.
3. Hertzberg MA, Feldman ME, Beckham JC, Kudler HS, Davidson JR: Lack of efficacy for fluoxetine in PTSD: a placebo-controlled trial in combat veterans. Ann Clin Psychiatry 2000; 12: 101-5.
4. 1-adrenergic antagonist prazosin ameliorates combat trauma nightmares in veterans with posttraumatic stress disorder: a report of 4 cases. J Clin Psychiatry 2000; 61: 129-33.
5. Nagy LM, Morgan CA, Southwick SM, Charney DS: Open prospective trial of fluoxetine for posttraumatic stress disorder. J Clin Psychopharmacol 1993; 13: 107-13.
6. Fichtner CG, Arora RC, O'Connor FL, Crayton JW: Platelet paroxetine binding and fluoxetine pharmacotherapy in posttraumatic stress disorder: preliminary observations on a possible predictor of clinical treatment response. Life Sci 1994; 54: 39-44.
7. Hamner MB, Frueh BC: Response to venlafaxine in previously antidepressant treatment-resistant combat veteran with post-traumatic stress disorder. Int J Clin Psychopharmacol 1998; 13: 233-4.
8. Connor KM, Sutherland SM, Tupler LA, Malik ML, Davidson JR: Fluoxetine in post-traumatic stress disorder: randomized, double-blind study. Br J Psychiatry 1999; 175: 17-22.
9. Stein DJ, Seedat S, van der Linden GJ, Zungu-Dirwayi N: Selective serotonin reuptake inhibitors in the treatment of post-traumatic stress disorder: a meta-analysis of randomized controlled trials. Int J Clin Psychopharmacol 2000; 15(Suppl 2): 31-9.
10. Canive JM, Clark RD, Calas LA, Qualls C, Tuason VB: Bupropion treatment in veterans with posttraumatic stress disorder: an open study. J Clin Psychopharmacol 1998; 13: 379-83.
11. Hertzberg MA, Butterfield MI, Feldman ME, et al: A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder. Biol Psychiatry 1999; 45: 1226-9.
12. Van der Kolk BA, Dreyfuss D, Michaels M, et al: Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry 1994; 55: 517-22.
13. Hertzberg MA, Feldman ME, Beckham JC, Moore SD, Davidson JR: Open trial of nefazodone for combat-related posttraumatic stress disorder. J Clin Psychiatry 1998; 59: 460-4.
14. Zisook S, Chentsova-Dutton YE, Smith-Vaniz A, et al: Nefazodone in patients with treatment-refractory posttraumatic stress disorder. J Clin Psychiatry 2000; 61: 203-8.
15. Mannar CR, Schoenfeld F, Weiss DS, et al: Open trial of fluvoxamine treatment for combat-related posttraumatic stress disorder. J Clin Psychiatry 1996; 57(Suppl 8): 66-70.
16. Fesler FA: Valproate in combat-related posttraumatic stress disorder. J Clin Psychiatry 1991; 52: 361-4.
17. Mellman TA, Kulick-Bell R, Ashlock LE, Nolan B: Sleep events among veterans with combat-related posttraumatic stress disorder. Am J Psychiatry 1995; 152: 110-5.
18. Neylan TC, Mannar CR, Metzler TJ, Weiss DS, Zatzick DF, Delucchi KL: Sleep disturbances in the Vietnam generation: findings from a nationally representative sample of male Vietnam veterans. Am J Psychiatry 1998; 155: 929-33.
19. Butler RW, Mueser KT, Sprock J, Braff DL: Positive symptoms of psychosis in posttraumatic stress disorder. Biol Psychiatry 1996; 39: 839-44.
20. David D, Kutcher GS, Jackson El, Mellman TA: Psychotic symptoms in combat-related posttraumatic stress disorder. J Clin Psychiatry 1999; 60: 29-32.
21. Hamner MB, Frueh BC, Ulmer HG, Arana GW: Psychotic features and illness severity in combat veterans with chronic posttraumatic stress disorder. Biol Psychiatry 1999; 45: 846-52.
22. Dillard ML, Bendfeldt F, Jemigan P: Use of thioridazine in post-traumatic stress disorder. South Med J 1993; 86: 1276-8.
23. Leyba CM, Wampler TP: Risperidone in PTSD. Psychiatric Serv 1998; 49: 245-6.
24. Krashnin D, Oates EW: Risperidone as an adjunct therapy for post-traumatic stress disorder. Milit Med 1999; 164: 605-6.
25. Eidelman I, Seedat S, Stein DJ: Risperidone in the treatment of acute stress disorder in physically traumatized in-patients. Depress Anxiety 2000; 11: 187-8.
26. Labbate LA, Douglas S: Olanzapine for nightmares and sleep disturbance in posttraumatic stress disorder. Can J Psychiatry 2000; 45: 667-8.
27. Hamner MB: Clozapine treatment for a veteran with comorbid psychosis and PTSD. Am J Psychiatry 1996; 153: 841.
28. Bartzokis G, Freeman TW, Roca V: Risperidone treatment for PTSD, Book of Abstracts, pp 111-56. Phoenix, AZ, The 41st Annual NCDEU Meeting, 2001.
29. Blake DD, Weathers FW, Nagy LM, et al: The development of a clinician-administered PTSD scale. J Trauma Stress 1995; 8: 75-90.
30. Ghaemi SN, Katzow JJ: The use of quetiapine for treatment-resistant bipolar disorder: a case series. Ann Clin Psychiatry 1999; 11: 137-40.
31. Zarate CA Jr, Rothschild A, Fletcher KE, Madrid A, Zapatel J: Clinical predictors of acute response with quetiapine in psychotic mood disorders. J Clin Psychiatry 2000; 61: 185-9.
32. Faustman WO, Ringo DL, Lauriello J, Lim KO, Pfefferbaum A: Effects of "Seroquel" (quetiapine) on platelet serotonin-2 binding in schizophrenia. J Clin Psychopharmacol 1996; 16: 464-6.
33. Garver DL: Review of quetiapine side effects. J Clin Psychiatry 2000; 61(Suppl 8): 31-5.
34. Jones HM, Travis MJ, Mulligan R, et al: In vivo 5-HT2A receptor blockade by quetiapine: an R91150 single photon emission tomography study. Psychopharmacology 2001; 157: 60-6.
35. Southwick SM, Krystal JH, Bremner JD, et al: Noradrenergic and serotonergic function in posttraumatic stress disorder. Arch Gen Psychiatry 1997; 54: 749-58.
36. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Ed 4. Washington, DC, American Psychiatric Association, 1994.
37. National Institute of Mental Health CGI (Clinical Global Impression) Scale-NIMH. Psychopharmacol Bull 1985; 21: 839-44.
38. Hammer MB, Deitsch SE, Brodrizk PS, Ulmer HG, Lorberhaum SP: Quetiapine treatment in patients with posttraumatic stress disorders: an open trial of adjunctive therapy. J Clin Psychophannacol 2003; 23: 15-20.
39. Small JG, Hirsch SR, Arvanitis LA, Miller BG, Link CG: Quetiapine in patients with schizophrenia: a high- and low-dose double-blind comparison with placebo. Arch Gen Psychiatry 1997; 54: 549-57.
40. McManus DQ, Arvanitis LA, Kowalcyk BB: Quetiapine, a novel antipsychotic: experience in elderly patients with psychotic disorders. J Clin Psychiatry 1999; 60: 292-8.